Overview

Effects of Oral Rabeprazole on the Prevention of Ulcer Bleeding Following Endoscopic Mucosal Resection

Status:
Completed
Trial end date:
2012-03-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is: - To examine if oral administration of Pariet (proton pump inhibitor, 20mg tablets, twice daily for 5 days) before Endoscopic mucosal resection(EMR) exhibits preventive effects of ulcer bleeding compared with placebo group (preoperative administration of placebo) - To evaluate the effects on the suppression of acid secretion of preoperative administration of an Proton pump inhibitor
Phase:
Phase 4
Details
Lead Sponsor:
The Catholic University of Korea
Collaborator:
Janssen Korea, Ltd., Korea
Treatments:
Rabeprazole